Skip to content

Obesity and Clinical and Cytokine Responses to Periodontal Therapy

Evaluation of Biochemical and Periodontal Parameters in Obese Individuals

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07869277
Enrollment
80
Registered
2026-10-09
Start date
2015-01-06
Completion date
2015-07-07
Last updated
2026-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, Obesity (Body Mass Index >30 kg/m2)

Keywords

obesity, inflammation, periodontal therapy, saliva, cytokines

Brief summary

This prospective controlled clinical study included 80 participants allocated into four groups according to body mass index (BMI) and periodontal status: obese periodontitis, normal-weight periodontitis, obese periodontally healthy, and normal-weight periodontally healthy. Clinical periodontal parameters and salivary levels of IL-6, IL-10, TNF-α, and adiponectin were assessed at baseline in all participants. Individuals with periodontitis received non-surgical periodontal therapy, and clinical and biochemical evaluations were repeated after 3 months.

Detailed description

This study was designed to investigate the interaction between obesity and periodontitis in terms of clinical periodontal status and systemic inflammatory burden, as well as to evaluate whether obesity modifies the response to non-surgical periodontal therapy. Participants were categorized into four groups according to body mass index (BMI) and periodontal status: obese individuals with periodontitis, normal-weight individuals with periodontitis, obese periodontally healthy controls, and normal-weight periodontally healthy controls. Clinical periodontal parameters, including probing pocket depth (PPD), clinical attachment level (CAL), plaque index (PI), and bleeding on probing (BOP), were recorded at baseline. Salivary inflammatory biomarkers, including C-reactive protein (CRP) and interleukin-6 (IL-6), were analyzed to assess systemic and local inflammatory profiles. Non-surgical periodontal therapy was performed in participants diagnosed with periodontitis. Clinical and salivary parameters were re-evaluated following treatment to determine therapeutic response. The primary objectives were: (1) to assess whether obesity is associated with differences in baseline periodontal and inflammatory parameters, and (2) to determine whether obesity influences the clinical and inflammatory outcomes of non-surgical periodontal therapy.

Interventions

Non-surgical periodontal therapy consisting of scaling and root planing was performed using hand and ultrasonic instruments under local anesthesia when necessary. Supra- and subgingival plaque and calculus were removed. Oral hygiene instructions were provided to all participants. Treatment was completed within the standard clinical protocol.

Sponsors

Emine Çifcibaşı
Lead SponsorOTHER
Istanbul University - Cerrahpasa
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Adults aged 25-50 years For periodontitis groups: diagnosis of periodontitis according to clinical criteria (presence of periodontal pockets and clinical attachment loss) For healthy control groups: absence of clinical signs of periodontitis Body mass index (BMI) ≥30 kg/m² for obese groups Body mass index (BMI) 18.5-24.9 kg/m² for normal-weight groups Systemically healthy individuals No periodontal treatment within the previous 6 months Willingness to participate and provide informed consent -

Exclusion criteria

Presence of systemic diseases that could affect periodontal status or inflammatory response (e.g., diabetes mellitus, autoimmune disorders) Use of antibiotics, anti-inflammatory drugs, or immunosuppressive medications within the past 3 months Periodontal treatment within the previous 6 months Current pregnancy or lactation History of smoking or current tobacco use Presence of acute oral infections other than periodontitis Any condition that could interfere with study participation or outcome assessment \-

Design outcomes

Primary

MeasureTime frameDescription
Change in Probing Pocket Depth (PPD) After Non-Surgical Periodontal TherapyBaseline to 3 monthsProbing pocket depth (PPD) was measured in millimeters using a Williams periodontal probe at baseline and at the 3-month follow-up. The change from baseline to 3 months was calculated to assess the clinical response to non-surgical periodontal therapy.
Change in Clinical Attachment Level (CAL) After Non-Surgical Periodontal TherapyBaseline to 3 monthsClinical attachment level (CAL) was measured in millimeters using a Williams periodontal probe at baseline and at the 3-month follow-up. The change from baseline to 3 months was calculated to assess the clinical response to non-surgical periodontal therapy.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 11, 2026